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Aim: Chronic kidney disease (CKD) has become a burden of health care globally. However, data on epidemiology, clinical features, and
outcomes of urinary tract infection (UTI) in this population are scarce. This study aims to retrospectively review such data.
Materials and methods: A retrospective cohort study was conducted from 1 January 2005 to 31 December 2011 in patients with CKD
requiring hospitalization. Patients who had upper and lower UTIs were compared for demography and clinical data. Logistic regression
was used to assess which variables were associated with upper UTI.
Results: A total of 276 bacteriuria patients were admitted to our ward with upper and lower UTIs. The average ages of the upper and
lower UTI patients were 59.21 ± 16.54 and 71.18 ± 14.77 years, respectively. The results of logistic regression analysis showed that age
(OR 0.946, P < 0.001), female sex (OR 4.695, P < 0.001), and renal stones (OR 8.232, P < 0.001) were independently associated with
upper UTI.
Conclusion: This study shows that patients with CKD and UTIs were elderly, and that females were prone to have more bacteriuria and
upper UTIs than males. In addition, patients who had renal stones were more prone to have upper UTI than other bacteriuria patients.
Aggressive treatment of renal stones should be considered in these patients.
Key words: Urinary tract infection, chronic kidney disease, renal failure, renal stones, bacteriuria

1. Introduction
Urinary tract infection (UTI) is not uncommon in females
and patients who are diabetic, are immunocompromised,
have anatomic abnormalities, are incontinent with
indwelling catheter, or are of advanced age (1–7). It is
also the most common bacterial infection acquired in
the community and in hospitals (8). Recurrent UTIs
are usually found in women and should receive further
treatment to prevent kidney damage (9). Chronic kidney
disease (CKD) may result from recurrent UTIs and
retrospective infection to the kidneys. However, there are
few studies of patients with CKD and UTI (10).
CKD has already become a burden of global health
(11,12). With advances in hemodialysis and medical care,
patients sustaining CKD have had prolonged survival. Even
so, these patients may have some medical problems that
cause CKD, such as diabetes mellitus (DM), uncontrolled
* Correspondence: wuziching88@yahoo.com.tw

high blood pressure, primary kidney diseases, or drug
toxicities, which may result in chronic medical problems.
They may have complications of reduced kidney function,
such as hypertension, malnutrition, anemia, bone disease,
and decreased quality of life (13). In addition, due to
prolonged hemodialysis that may compromise their
immune system, they are vulnerable to infection, including
UTIs. Nevertheless, the incidence of UTIs in patients with
CKD is unclear and the literature on the management
of UTIs in these patients is sparse (14). Besides, to our
knowledge, the literature has not addressed the differences
of demographic and urological variables between upper
and lower UTIs in patients with CKD.
In this study, we retrospectively reviewed patients who
had CKD with UTIs and compared patient demography,
medical histories, and infecting bacteria between upper
and lower UTIs. The objectives of this study were to
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address some of the shortcomings of the literature and to
seek to understand the differences of demographic and
urological variables between upper and lower UTIs in
patients with CKD.
2. Materials and methods
2.1. Study subjects and setting
We conducted a retrospective cohort study by reviewing
the records for all patients who had CKD sustaining
bacteriuria with UTI and were admitted to our nephrology
ward in the middle county of Taiwan over the 6-year period
from 1 January 2005 to 31 December 2011. The medical
facility, located in the center of a county with a population
of 547,709 people, provides health care with 1000 hospital
beds, an outpatient department serving approximately
3800 persons daily, and an emergency department serving
260 persons daily. We included patients who had CKD
sustaining bacteriuria with UTI during admission to our
hospital from the emergency department or outpatient
clinic. Patients on admission found to be without
bacteriuria, who had CKD and were on dialysis therapy,
who had been transferred from other facilities, who had
received antibiotic treatments before urine culture, or who
lacked complete chart records were all excluded.
Although this was a retrospective study, all data
collected in this study were recorded prospectively when
patients were admitted to the hospital. A standard form
for chart review was used for data collection. To ensure the
accuracy of the data, charts were reviewed and encoded by
a senior training nurse for full-time research and doublechecked by a nephrologist for demographic information
and clinical data, including types of antibiotic treatment,
stage of CKD, associated concomitant infections,
management scheme, adjunctive treatment, and outcome.
Review meetings were held to resolve disputed coding
errors on a weekly basis.
Among patients with CKD, the stage of disease was
assigned based on the level of kidney function, irrespective
of diagnosis, according to the Kidney Disease Outcomes
Quality Initiative CKD classification (15). We reviewed
medical records of the patients and determined the stage
of CKD when bacteriuria was diagnosed at our hospital.
Stage I was kidney damage with normal or high glomerular
filtration rate (GFR) of 90 mL/min or more; stage II was a
mild decrease in GFR to 60 to 89 mL/min; stage III was a
moderate decrease in GFR to 30 to 59 mL/min; stage IV
was a severe decrease in GFR to 15 to 29 mL/min; and
stage V was kidney failure with GFR of less than 15 mL/
min or on dialysis.
The indications to culture the urine were tested in
symptomatic patients with UTI or UTI suspicion, or
under certain circumstances in risk groups with fever.
A midstream clean-catch urine sample was collected by
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standard procedure. For catheterized specimens, a trained
health care provider inserted a thin rubber tube or catheter
through the urethra into the bladder and the urine sample
was taken and placed in a sterile container at the other end
of the tube. Bacteriuria was defined as any microorganisms
present (growth of 100,000 CFU/mL bacteria in the
culture) in the urine sample growing over the next 24 to
48 h as small circular colonies when urine was placed on 1
or more agar plates and incubated at body temperature. If
there was more than 1 type of bacteria present in relatively
large numbers, clinical symptoms were reviewed and it was
determined by a nephrologist whether the colonies came
from contamination of the skin picked up during the urine
collection or by true infection. Bacteriuria patients who
had pyelonephritis, renal abscess, and emphysematous
pyelonephritis were defined as having upper UTIs, while
cystitis and urethritis were defined as lower UTIs. Patients
admitted to our ward with flank pain and fever received
abdominal echogram and X-ray for further evaluation of
the causes. Abdominal computed tomography (CT) was
arranged according to further findings of a previous survey
or if it was known from patient history that he or she
suffered from renal stones. Patients who had renal stones
were diagnosed by X-ray, abdominal CT, or echogram.
Blood samples were drawn along with urine collection
for laboratory tests and cultures for aerobic and anaerobic
bacteria during admittance to the ward or our emergency
department before antibiotics treatment.
In our hospital, patients with UTIs caused by bacteria are
treated with antibiotics as suggested by the nephrologist or
infection specialist. All patients with CKD included in this
study received regular follow-up at our outpatient clinic
and were followed for more than 6 months. If the patient’s
renal function deteriorated, hemodialysis was regularly
performed at our hospital. Patients were considered for
long-term Foley insertion if they had difficulty voiding
without antibiotics treatment if no severe symptoms of
infection were found.
2.2. Statistical analysis
Patient demographics, laboratory data, and selected
variable relationships were characterized using descriptive
statistics with the mean and standard deviations.
Categorical variables were analyzed using chi-square
analysis. One-way analysis of variance (ANOVA) was
performed comparing stage of CKD against creatinine
(Cr). Patients were divided into upper and lower UTI
groups. The demographic and clinical characteristics
between groups were evaluated using univariate analysis.
For continuous variables, Student t-tests were used to
compare means for normal distributed data, while the
Pearson chi-square test was used for categorical variables;
Fisher exact tests and continuity corrections were used
where appropriate. A forward stepwise logistic regression
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was applied to determine the predictors for upper UTIs.
All variables in the univariate analysis with 2-sided
P-values of ≤0.20 were candidates for inclusion in the
logistic regression model to assess which variables were
associated with upper UTIs. Using a stepwise selection
method, individual covariates were retained in the final
model based on the maximization of model fit (r2), while
taking into account each additional covariate selected. A
P-value of less than 0.05 was considered significant. All
data were analyzed using qualified statistical software
(SPSS for Windows 15; SPSS Inc., Chicago, IL, USA).
3. Results
A total of 276 bacteriuria patients were admitted to our
ward with symptoms of upper UTIs and possible lower
UTIs from 1 January 2005 to 31 December 2011. Among
these patients, 73 patients (26.4%, 73/276) were confirmed
to have upper UTIs and 203 patients were found to have
lower UTIs (73.6%, 203/276) without progression to the
kidneys. The average ages of the upper and lower UTI
patients were 59.21 ± 16.54 and 71.18 ± 14.77 years, and
so the patients who had upper UTIs were younger than
those with lower UTIs (P < 0.001). There was significant
difference in the numbers according to sex between
patients of the 2 groups (P < 0.001). Females (36.1%,
60/166) were more prone to have upper UTIs than males
(11.8%, 13/110).

Of these 276 patients, 38 (13.8%) had stage I CKD (Cr
1.40 ± 1.79), 91 (33.0%) stage II CKD (Cr 1.21 ± 1.00), 102
(37.0%) stage III CKD (Cr 1.79 ± 1.21), 37 (13.4%) stage
IV CKD (Cr 2.94 ± 2.26), and 8 (2.9%) stage V CKD (Cr
4.97 ± 2.56). There was a statistically significant difference
of Cr levels between the different stages of CKD (P <
0.001). Nevertheless, there was no significant difference in
the stage between the 2 groups.
When the 2 groups were compared for DM,
hypertension, liver cirrhosis, and renal stones (P = 0.396,
0.309, 0.604, and <0.001, respectively), only renal stones
had a significant difference between the groups. Foley
catheter insertion was also compared between the 2
groups (P < 0.001). However, 32 patients who had Foley
insertion had UTIs and only 1 of these patients had an
upper UTI (Table 1). When bacteria of infections between
upper and lower UTIs were compared, there were no
significant differences between the bacteria in the 2 groups
(P = 0.903).
The results of logistic regression analysis showed that
age (OR 0.946, 95% CI 0.926 to 0.967, P < 0.001), female
sex (OR 4.695, 95% CI 2.173 to 10.146, P < 0.001), and
renal stones (OR 8.232, 95% CI 3.450 to 19.646, P < 0.001)
were independently associated with upper UTIs after
adjustment for DM, liver cirrhosis, and Foley insertion
(Table 2). The model adequately fitted the data with
Hosmer–Lemeshow statistics (P = 0.110).

Table 1. Demographics, averaged physiological parameters, and variables in both UTI groups.
Variables

Upper UTI (n = 73)

Lower UTI (n = 203)

P-value

Age

59.21 ± 16.54

71.18 ± 14.77

<0.001†

Sex (Female)

60 (82.2%)

106 (52.2%)

<0.001*

Hypertension

26 (35.6%)

64 (31.5%)

0.523*

DM

25 (34.2%)

75 (36.9%)

0.396*

Liver cirrhosis

3 (4.1%)

9 (4.4%)

0.907*

Renal stones

25 (34.2%)

17 (8.4%)

<0.001v

Foley insertion

1 (1.4%)

31 (15.3%)

0.001*

Escherichia coli

43 (58.9%)

104 (51.2%)

0.260*

Proteus

6 (8.2%)

6 (3.0%)

0.059*

Klebsiella

3 (4.1%)

16 (7.9%)

0.275*

Enterococcus

0 (0%)

12 (5.9%)

0.034*

Pseudomonas

2 (2.7%)

14 (6.9%)

0.192*

Staphylococcus

0 (0%)

1 (0.5%)

0.548*

Bacteria

P-values are based on the chi-square test (*) and on the Student t-test (†).
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Table 2. Independent risk factors* associated with upper UTI.
OR

95% CI

P

Age

0.954

0.935–0.973

<0.001

Sex (Female)

4.695

2.178–9.968

<0.001

Renal stones

7.927

3.372–18.635

<0.001

Foley insertion

7.167

0.884–58.121

0.065

*: The risk factors included in the logistic regression model were age, sex, renal stones, and Foley
insertion.

4. Discussion
In our study, we found that patients who were younger,
were female, and had renal stones with urobacteria were
more prone to have upper UTIs, and patients who had
indwelling urinary catheters were more prone to have
lower rather than upper UTIs. However, we did not found
any statistical differences of infective bacteria between the
upper and lower UTI groups in patients with CKD.
In a study by Zhang et al., they found a high prevalence
(17.4%) of CKD among older adults (50 to 74 years) from
9806 participants (13). In our patients with CKD, we found
that although these patients were mostly seniors, patients
who had upper UTIs (59.21 ± 16.54 years) were younger
than those with lower UTIs (71.18 ± 14.77 years).
Females are prone to UTIs due to the shortness of the
urethra, which is close to the vagina and anus; the lack of
prostatic fluid, which has antibacterial activity; or the use
of spermicides and/or diaphragms (16). In our study, we
found that there were more females than males in both
the upper and lower UTI groups. In addition, about 25%
of our patients who had a lower UTI developed an upper
UTI, and the number of females was triple that of males.
Since women have up to a 10% risk of recurrent acute
pyelonephritis in the year following the first acute episode
and the equivalent risk in men is 6% (17), the findings may
result from recurrent lower UTIs finally developing into
upper UTIs.
In this study, we found that Escherichia coli was the
bacteria infecting half of the patients regardless of sex.
Since Escherichia coli is the most infective bacteria in
UTI patients (18), it is not surprising that it also infected
half of the patients with CKD. In addition, we found that
there was no statistical difference in the bacteria cultured
from upper or lower UTIs. In a previous study, the most
frequent cause of upper UTI was also E. coli (19). Thus,
empirical use of antibiotics in these patients with gramnegative infection is still effective in patients with CKD.
Urolithiasis was a potential cause of upper UTI in
our patients with a higher odds ratio. In previous studies,
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urolithiasis was found to be one of the risk factors of
subsequent treatment failure of or mortality from upper
UTI (20,21). Due to patients with CKD being prone to
having more medical problems, we suggest that early
management of urolithiasis is critical in these patients to
prevent further subsequent infection and damage to their
kidneys.
Catheter-associated UTI is the most common of
health care-associated infections (22). In our study, of the
32 patients with a urinary catheter, only 1 patient had an
upper UTI. However, in patients with CKD who needed
catheterization, the conditions were more complicated,
with different underlying diseases. The relationship
between catheterization and upper UTIs needs to be
further determined.
There are some limitations of this study. One set
of limitations is inherent in retrospectively reviewing
medical records; therefore, the presence of symptoms
could not be fully ascertained. However, although reviews
were retrospective, the strengths of this study are the large
number of patients included, its prospective collection,
and the comprehensive clinical and microbiologic data
gathered. Nevertheless, because this study was conducted
at a single center and the sample size was relatively small for
the subgroup of patients with catheter-associated urinary
tract infection and the subgroup of bacterial infection, the
results of statistic analyses may not be significant. Besides, as
we defined “upper UTI” as emphysematous pyelonephritis,
renal abscess, or acute pyelonephritis by image study or
with typical features of urinary frequency/dysuria, flank
tenderness, and high-grade fever accompanied by typical
laboratory and microbiological findings, it is possible
that this limitation may have hampered our ability to
more precisely define the diagnostic role of upper UTIs.
Another set of limitations may result from the patients
with CKD having variants of underlying diseases with
previous antibiotics treatment, which may confound the
risk for upper UTI. This approach might lead to some
underestimation of upper UTI in CKD.
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In conclusion, in our study, females were more prone
bacteriuria and upper UTIs than males among CKD
patients. Bacterial infections between the upper and lower
UTI groups showed no statistical difference. Therefore,
an upper UTI infection may result from retrospective
infection from a lower UTI. Treatment of CKD patients
with upper UTIs can include empiric antibiotics according
to the bacteriuria. Patients who had renal stones were
more prone to having upper UTI as compared to other

bacteriuria patients. Aggressive treatment of renal stones
should be considered in such patients.
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